Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 1,794,894 | 0 | 47 | 11 | 9 |
| Gross Profit | 1,794,894 | N/A | 47 | 11 | 9 |
| Operating Expenses | 430,448 | 0 | 17,320 | 29,203 | 32,544 |
| Operating Income | 1,364,446 | N/A | -17,273 | -29,192 | -32,535 |
| Interest Expense | 279,956 | 0 | 0 | 0 | 0 |
| Other Income | 433,365 | 0 | 0 | 0 | 0 |
| Pre-tax Income | 1,517,855 | 0 | -17,273 | -29,192 | -32,535 |
| Net Income Continuous | 1,517,855 | N/A | -17,273 | -29,192 | -32,535 |
| Minority Interests | 140,126 | N/A | N/A | N/A | N/A |
| Net Income | $1,377,729 | $N/A | $-17,273 | $-29,192 | $-32,535 |
| EPS Basic Total Ops | N/A | N/A | -0.70 | -1.20 | -1.39 |
| EPS Basic Continuous Ops | N/A | N/A | -0.70 | -1.20 | -1.39 |
| EPS Diluted Total Ops | N/A | N/A | -0.70 | -1.20 | -1.39 |
| EPS Diluted Continuous Ops | N/A | N/A | -0.70 | -1.20 | -1.39 |
| EBITDA(a) | $1,410,840 | $N/A | $-17,268 | $-29,168 | $-32,492 |